INCIDENCES OF ALL MALIGNANCIES IN PATIENTS WITH CHRONIC HEPATITIS B RECEIVING LONG-TERM ORAL NUCLEOS(T)IDE ANALOGUE TREATMENT - A STUDY OF 45,299 SUBJECTS

被引：0
|
作者：
Wong, G. L. -H. [1 ]
Tse, Y. -K [1 ]
Wong, V. [1 ]
Yip, T. [2 ]
Chan, H. [1 ]
机构：
[1] CUHK, Med & Therapeut, Hong Kong, Hong Kong, Peoples R China
[2] CUHK, Stat, Hong Kong, Hong Kong, Peoples R China
来源：
JOURNAL OF HEPATOLOGY | 2016年 / 64卷
关键词：
D O I：
10.1016/S0168-8278(16)00071-4
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
PS052
引用
收藏
页码：S163 / S163
页数：1
相关论文
共 50 条
  • [1] RENAL AND BONE EVENTS IN PATIENTS WITH CHRONIC HEPATITIS B RECEIVING LONG-TERM ORAL NUCLEOS(T)IDE ANALOGUE TREATMENT - A STUDY OF 53,500 SUBJECTS
    Wong, G. L.
    Tse, Y. -K.
    Wong, V. W.
    Fung, T. Y.
    Chan, H. L.
    JOURNAL OF HEPATOLOGY, 2015, 62 : S564 - S564
  • [2] Safety of long-term nucleos(t)ide treatment in chronic hepatitis B
    Ridruejo, Ezequiel
    Silva, Marcelo O.
    EXPERT OPINION ON DRUG SAFETY, 2012, 11 (03) : 357 - 360
  • [3] Trajectories of serum hepatitis B surface antigen kinetics in patients with chronic hepatitis B receiving long-term nucleos(t)ide analogue therapy
    Hsu, Wei-Fan
    Chen, Chuen-Fei
    Lai, Hsueh-Chou
    Su, Wen-Pang
    Lin, Chia-Hsin
    Chuang, Po-Heng
    Chen, Sheng-Hung
    Chen, Ching-Hsiang
    Wang, Hung-Wei
    Huang, Guan-Tarn
    Peng, Cheng-Yuan
    LIVER INTERNATIONAL, 2018, 38 (04) : 627 - 635
  • [4] Long-term outcome of entecavir treatment of nucleos(t)ide analogue-naive chronic hepatitis B patients in Japan
    Suzuki, Fumitaka
    Hosaka, Tetsuya
    Suzuki, Yoshiyuki
    Sezaki, Hitomi
    Akuta, Norio
    Fujiyama, Shunichiro
    Kawamura, Yusuke
    Kobayashi, Masahiro
    Saitoh, Satoshi
    Arase, Yasuji
    Ikeda, Kenji
    Kobayashi, Mariko
    Mineta, Rie
    Suzuki, Yukiko
    Kumada, Hiromitsu
    JOURNAL OF GASTROENTEROLOGY, 2019, 54 (02) : 182 - 193
  • [5] Considerations for the long-term treatment of chronic hepatitis B with nucleos(t)ide analogs
    Petersen, Joerg
    Buti, Maria
    EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2012, 6 (06) : 683 - 694
  • [6] Long-term safety of oral nucleos(t)ide analogs for patients with chronic hepatitis B: A cohort study of 53,500 subjects
    Wong, Grace Lai-Hung
    Tse, Yee-Kit
    Wong, Vincent Wai-Sun
    Yip, Terry Cheuk-Fung
    Tsoi, Kelvin Kam-Fai
    Chan, Henry Lik-Yuen
    HEPATOLOGY, 2015, 62 (03) : 684 - 693
  • [7] A long-term multicenter study: Entecavir versus Tenofovir in treatment of nucleos(t)ide analogue-naive chronic hepatitis B patients
    Kayaaslan, Bircan
    Akinci, Esragul
    Ari, Alpay
    Tufan, Zeliha Kocak
    Alpat, Saygin Nayman
    Gunal, Ozgur
    Tosun, Selma
    Guner, Rahmet
    Tabak, Fehmi
    CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY, 2018, 42 (01) : 40 - 47
  • [8] Reduction of covalently closed circular DNA with long-term nucleos(t)ide analogue treatment in chronic hepatitis B
    Lai, Ching-Lung
    Wong, Danny
    Ip, Philip
    Kopaniszen, Malgorzata
    Seto, Wai-Kay
    Fung, James
    Huang, Fung-Yu
    Lee, Brian
    Cullaro, Giuseppe
    Chong, Chun Kong
    Wu, Ringo
    Cheng, Charles
    Yuen, John
    Ngai, Vincent
    Yuen, Man-Fung
    JOURNAL OF HEPATOLOGY, 2017, 66 (02) : 275 - 281
  • [9] The incidence of hepatocellular carcinoma is reduced in patients with chronic hepatitis B on long-term nucleos(t)ide analogue therapy
    Coffin, C. S.
    Rezaeeaval, M.
    Pang, J. X.
    Alcantara, L.
    Klein, P.
    Burak, K. W.
    Myers, R. P.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2014, 40 (11-12) : 1262 - 1269
  • [10] Long-term outcome of entecavir treatment of nucleos(t)ide analogue-naïve chronic hepatitis B patients in Japan
    Fumitaka Suzuki
    Tetsuya Hosaka
    Yoshiyuki Suzuki
    Hitomi Sezaki
    Norio Akuta
    Shunichiro Fujiyama
    Yusuke Kawamura
    Masahiro Kobayashi
    Satoshi Saitoh
    Yasuji Arase
    Kenji Ikeda
    Mariko Kobayashi
    Rie Mineta
    Yukiko Suzuki
    Hiromitsu Kumada
    Journal of Gastroenterology, 2019, 54 : 182 - 193
12345